SCHLIEREN (ZURICH), Switzerland, July 02, 2018 (GLOBE NEWSWIRE) — Kuros Biosciences (SIX:KURN) announced today it recorded the first commercial use last week of MagnetOs in the U.S., and the company expects to ramp up its commercial activities in Europe and the U.S. in the second half of 2018. Joshua M. Ammerman, M.D. of Washington Neurosurgical […]
All News
ATLANTA, July 02, 2018 (GLOBE NEWSWIRE) — Medovex Corp. (OTCQB:MDVX) (“Medovex” or the “Company”), the developer of the DenerveX® System, a new and novel device designed for enduring relief of Facet Joint Syndrome related to chronic back pain, a non-addictive, non-opioid drug alternative capable of restoring a patient to a more normal and active lifestyle, […]
LEESBURG, Va., July 02, 2018 (GLOBE NEWSWIRE) — K2M Group Holdings, Inc. (NASDAQ:KTWO) (the “Company” or “K2M”), a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional Total Body Balance™, today announced that second quarter of fiscal year 2018 financial results will be released after the market close on August 1, […]
FRANKLIN, Mass., June 29, 2018 /PRNewswire/ — Today, Arthrosurface, Inc., a leading provider of minimally invasive, motion preserving joint restoration systems, announces their recent FDA 510(k) Clearance to market the Patellofemoral (PF) WaveKahuna Arthroplasty System. The PF WaveKahuna Arthroplasty System is a line extension to The Company’s previously cleared and commercially marketed family of HemiCAP® Patellofemoral & PF Wave Systems. Shane […]
June 28, 2018 NAPLES, Fla.–(BUSINESS WIRE)–Catalyst OrthoScience Inc., a cutting-edge medical device company focused on the upper extremity orthopedics market, today announced the addition of Brian K. Hutchison to its board of directors as executive chair. Hutchison will also serve as interim chief executive officer of the company until a permanent CEO is in place. Hutchison […]
JUN 28, 2018 Episurf Medical (NASDAQ: EPIS B) today announces that the company has reached an important milestone on its strategy to reach the US market. The Investigational Device Exemption (IDE) application that the company has been working on is ready for filing. The application will now be filed to the US Food and Drug […]
June 27, 2018 PARIS–(BUSINESS WIRE)–Regulatory News: EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI – Eligible PEA – PME), the pioneer of 2D/3D imaging and data solutions for orthopedics, today announced the installation of an EOS® imaging system at ATOS Klinik Heidelberg, establishing it as first private practice in Germany to offer the low-dose 2D/3D imaging system. […]
© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1